Gerhard Boost
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Reproductive Medicine top 10%
- Endometriosis Research and Treatment
Papers in
-
- Inflammatory mediators and NSAID effects 6
- Pharmacogenetics and Drug Metabolism 1
-
- Rheumatoid Arthritis Research and Therapies 3
- Co-authors
- Eugene J. Segre (5 shared papers)Enrico Forchielli (3 shared papers)Richard Runkel (2 shared papers)M. D. Chaplin (2 shared papers)Robert E. Smith (1 shared paper)Milan R. Henzl (1 shared paper)Edward T. Tyler (1 shared paper)Sanford H. Roth (1 shared paper)
- Journals
- Scandinavian Journal of Rheumatology (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)Clinical Pharmacology & Therapeutics (1 paper)The Journal of Clinical Pharmacology (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Gerhard Boost
10 papers receiving 300 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 197
- Pharmacology 69
- Reproductive Medicine 58
- Analytical Chemistry 52
- Biochemistry 28
Countries citing papers authored by Gerhard Boost
This map shows the geographic impact of Gerhard Boost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Boost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Boost more than expected).
Fields of papers citing papers by Gerhard Boost
This network shows the impact of papers produced by Gerhard Boost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Boost. The network helps show where Gerhard Boost may publish in the future.
Co-authors
The 15 scholars most cited alongside Gerhard Boost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 152 | |
| 2 | 1972 | 81 | |
| 3 | 1973 | 44 | |
| 4 | 1972 | 34 | |
| 5 | 1975 | 29 | |
| 6 | 1973 | 23 | |
| 7 | 1973 | 10 | |
| 8 | [Clinical-pharmacological and pharmacokinetic studies with naproxen]. | 1975 | 6 |
| 9 | Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritis. | 1973 | 4 |
| 10 | [Long-term therapy of progressive chronic polyarthritis with naproxen]. | 1975 | 2 |
About Gerhard Boost
Gerhard Boost is a scholar working on Pharmacology, Rheumatology, Analytical Chemistry, Biochemistry and Immunology, having authored 10 papers that have together received 385 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Endometriosis Research and Treatment (1 paper) and Ovarian function and disorders (1 paper). The work is most often cited by research in Pharmacology (197 citations), Pharmacology (69 citations), Reproductive Medicine (58 citations), Analytical Chemistry (52 citations) and Biochemistry (28 citations). Gerhard Boost has collaborated with scholars based in United States and Canada. Frequent co-authors include Eugene J. Segre, Enrico Forchielli, Richard Runkel, M. D. Chaplin, Robert E. Smith, Milan R. Henzl, Edward T. Tyler, Sanford H. Roth, Hilli Sevelius and Robert E. Hill. Their work appears in journals such as Scandinavian Journal of Rheumatology, The Journal of Clinical Endocrinology & Metabolism, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.